Good news for people that are afraid of needles and/or blood. On Thursday the U.S. FDA cleared Seventh Sense Biosystem’s TAP phlebotomy device for use in hemoglobin A1c (HbA1c) testing, a standard ...
Seventh Sense Biosystems picked up a $10 million Series C to develop new products around and to expand manufacturing capacity for its “push-button” blood collection device. The TAP device is placed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results